Clinical Trial Update: Use of SBI in IBS Subjects Following a Successful Treatment of Small Intestinal Bacterial Overgrowth [NA]

View source ↗

Summary

Clinical trial update announcing completion of a study evaluating SBI in patients with diarrhea-predominant irritable bowel syndrome following treatment of smal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome Diarrhea Predominant
• Small Intestinal Bacterial Overgrowth

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Diarrhea Predominant Irritable Bowel Syndrome, Small Intestinal Bacterial Overgrowth | NA | Status: COMPLETED